Solara Active Pharma Sciences has informed that it enclosed a press release issued by the Company titled hereunder, with respect to the EIR (Establishment Inspection Report) received from US FDA for the inspection completed and classified as VAI (Voluntary Action Indicated). ‘Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP’.
The above information is a part of company’s filings submitted to BSE.